ISOO 2022: Educational Session Highlighting Retrospective Study of Belzupacap Sarotalocan versus Radiotherapy in Choroidal Melanoma

Topline Data from a Retrospective, Matched Case Study Evaluating Belzupacap Sarotalocan (AU-011) versus Plaque Radiotherapy, Supports the Value of a Vision Preserving Therapy for the Treatment of Patients with Early-Stage Choroidal Melanoma